title: [Necessary diagnostic and therapeutic measures in the rehabilitation of "cured" patients with Hodgkin's disease].
abstract: On account of the fundamental changes in treatment modalities, an ameliorated prognostic outlook, as well as a not inconsiderable variety of reversible and irreversible treatment-generated disorders, current concepts for rehabilitation of patients with M. Hodgkin require thorough reconsideration. It is not the early detection of recidives, but identification and, whenever possible, therapy of the treatment aftermath that should be the primary function of tumour aftercare. Splenectomy, radiotherapy, and chemotherapy may entail long-term immune-system or cardiac disorders, scelettal impairments, functional disorders of the lung, liver, kidney, or the endocrine system, vascular diseases, dental problems, leukeamia, or second carcinoma. As primary therapy is increasingly being geared toward taking into account this possible aftermath of treatment, aftercare and rehabilitation of patients with M. Hodgkin, too, should be adjusted to an increased awareness of unwanted long-term side-effects.
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001847:Bone Diseases / Q000534:rehabilitation; D056486:Chemical and Drug Induced Liver Injury / Q000534:rehabilitation; D003131:Combined Modality Therapy; D005260:Female; D006321:Heart / Q000528:radiation effects; D006402:Hematologic Diseases / Q000534:rehabilitation; D006689:Hodgkin Disease / Q000276:immunology / Q000534:rehabilitation*; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000534:rehabilitation; D007246:Infertility / Q000534:rehabilitation; D007674:Kidney Diseases / Q000534:rehabilitation; D008171:Lung Diseases / Q000534:rehabilitation; D008297:Male; D011379:Prognosis; D011832:Radiation Injuries / Q000534:rehabilitation; D013961:Thyroid Gland / Q000528:radiation effects
vernacular_title: Notwendige diagnostische und therapeutische Massnahmen bei der Rehabilitation "geheilter" Patienten mit Morbus Hodgkin.